Working Hours
Mon - Sat 9:00 - 6:00




Price:
Price 169.0 INR / Piece
Minimum Order Quantity : 50 Pieces
Quantity : 50 Pieces
Ingredients : Brand Name: CEFACTAM FORTE Generic Name / Content: Cefoperazone & Sulbactam for Injection 1.5 g Company: Aurobindo Pharma Ltd CEFACTAM FORTE 1.5 g Injection is a combination antibiotic containing Cefoperazone (a thirdgeneration cephalosporin) and Sulbactam (a betalactamase inhibitor). This dualaction formulation provides broadspectrum antibacterial coverage and is effective against betalactamase producing organisms. Cefoperazone works by inhibiting bacterial cell wall synthesis, while Sulbactam enhances its activity by preventing enzymatic degradation. The injection is intended for intravenous (IV) or intramuscular (IM) administration in hospital and clinical settings. Indications Lower and upper respiratory tract infections Urinary tract infections (UTIs) Intraabdominal infections Skin and soft tissue infections Bone and joint infections Septicemia and bacteremia Gynecological infections Key Features Thirdgeneration cephalosporin with betalactamase inhibitor Broadspectrum antibacterial activity Effective against resistant organisms Sterile injectable formulation Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 1.5 g per vial Content: Cefoperazone + Sulbactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision
Drug Type : Other, Allopathic
Physical Form : Other
Price 95.0 INR / Piece
Minimum Order Quantity : 50 Pieces
Quantity : 50 Pieces
Ingredients : Brand Name: LINTAZ 4.5 G Generic Name / Content: Piperacillin + Tazobactam Injection I.P. 4.5 g Company: Aurobindo Pharma Ltd LINTAZ 4.5 G Injection is a broadspectrum injectable antibiotic combining Piperacillin (a penicillinclass antibiotic) and Tazobactam (a betalactamase inhibitor). This dualaction formulation provides enhanced efficacy against betalactamase producing bacteria, covering a wide range of Grampositive and Gramnegative infections. Piperacillin disrupts bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation, ensuring stronger antibacterial activity. The sterile injectable form is intended for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings. Indications Severe respiratory tract infections (pneumonia, bronchitis) Urinary tract infections (UTIs) Skin and soft tissue infections Intraabdominal infections Septicemia and bacteremia Gynecological infections Surgical prophylaxis Key Features Broadspectrum penicillin with betalactamase inhibitor Effective against resistant bacterial strains Rapid and reliable antibacterial action Sterile injectable formulation suitable for hospital use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 4.5 g per vial Content: Piperacillin + Tazobactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision
Drug Type : Injection
Physical Form : Liquid
Price 88.0 INR / Piece
Minimum Order Quantity : 50 Pieces
Quantity : 50 Pieces
Ingredients : LORTINIL TZ Injection Ceftazidime & Tazobactam Brand Name: LORTINIL TZ Composition: Ceftazidime & Tazobactam Injection Manufacturer/Marketer: Aurobindo Pharma Ltd Veritaz Division Dosage Form: Dry Powder for Injection Packaging Type: Vial Route of Administration: Intravenous (IV) / Intramuscular (IM) Prescription Required: Yes Product Description: LORTINIL TZ Injection is a broadspectrum antibiotic combination containing Ceftazidime and Tazobactam. Ceftazidime is a thirdgeneration cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Tazobactam is a betalactamase inhibitor that enhances the effectiveness of Ceftazidime against resistant bacterial strains. It is widely used in hospitals and clinical settings for the treatment of moderate to severe bacterial infections. Indications: Respiratory tract infections Urinary tract infections Intraabdominal infections Skin and soft tissue infections Bone and joint infections Septicemia Key Features: Broadspectrum antibacterial coverage Effective against betalactamase producing organisms Suitable for critical care and hospital use Manufactured by a reputed pharmaceutical company Storage: Store in a cool, dry place below 25 C. Protect from light and moisture. Note: To be administered under the supervision of a qualified healthcare professional only.
Drug Type : Injection
Physical Form : Liquid
Price 419.5 INR / Piece
Minimum Order Quantity : 50 Pieces
Quantity : 50 Unit
Ingredients : ROPIN 0.20% 50ML Ropivacaine Hydrochloride Injection I.P. Brand: ROPIN Injection Content: Ropivacaine Hydrochloride I.P. 0.2% w/v (2 mg / ml) Company / Manufacturer: Neon Laboratories Ltd Pack: 50 ml Vial Category: Local Anesthetic / AmideType Regional AnestheticProduct Description ROPIN 0.20% 50ml Vial contains Ropivacaine Hydrochloride, a longacting amidetype local anesthetic solution formulated for parenteral administration. The 0.2% concentration is specifically designed to provide effective sensory nerve blockade while minimizing motor block, making it ideal for continuous pain relief. It is widely used in postoperative wards, intensive care units, and delivery rooms to provide stable, longlasting regional pain control during surgical recovery or childbirth with enhanced systemic safety margins.Key Uses Production of continuous epidural infusion analgesia for labor pain management during childbirth Postoperative pain management following major orthopedic, abdominal, or thoracic surgeries Continuous peripheral nerve blocks and infiltration anesthesia for local pain control Longterm acute pain management in intensive care settings How It Works Ropivacaine works by blocking the generation and conduction of nerve impulses. It diffuses into the nerve sheath and binds selectively to the intracellular sodium channels of nerve fibers. This action prevents the influx of sodium ions through the cell membrane, stopping the electrical depolarization of the nerve cell. By blocking these pathways, the drug temporarily prevents pain signals from traveling from the affected site up the spinal cord to the brain.Directions for Use Administer via epidural infusion, peripheral nerve block, or local tissue infiltration routes Visually check the solution inside the vial for any particles, leaks, or cloudiness before extraction Extract using clean, sterile syringes directly through the rubber stopper core Must be calculated, handled, and administered exclusively by a registered anesthesiologist or clinician Key Features Optimized concentration that provides reliable pain relief with minimal loss of skeletal muscle control Extended therapeutic window that delivers prolonged postsurgical and labor analgesia High volume 50 ml vial format designed to support continuous infusion pumps or repeated dosing protocols Fabricated under international sterile manufacturing standards by Neon Laboratories Ltd Possible Side Effects Hypotension or sudden temporary drop in systemic blood pressure Nausea, vomiting, or mild dizziness Important Safety Notes Storage Temperature: Store below 30 C in a cool, dry place. Protect from direct light lines and do not freeze. For local and regional blocks only; strictly contraindicated for intravenous regional anesthesia methods Avoid application directly into highly inflamed or infected tissue surfaces Schedule H Prescription Drug: Restricted for institutional supply to verified buyers with drug wholesale licenses
Drug Type : Injection
Physical Form : Liquid
